|Identification of a novel neuronal C-SRC exon expressed in human brain.
|pp60c-src activation in human colon carcinoma.
|Isolation of duplicated human c-src genes located on chromosomes 1 and 20.
|Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src.
|Neuron-specific splicing of C-SRC RNA in human brain.
|Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.
|DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes.
|Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).
|Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
|Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527.
|Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
|Highly specific antibody to Rous sarcoma virus src gene product recognizes nuclear and nucleolar antigens in human cells.
|Cdc2-mediated modulation of pp60c-src activity.
|Regulation, substrates and functions of src.
|Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.
|Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases.
|Three-dimensional structure of the tyrosine kinase c-Src.
|Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
|Cellular functions regulated by Src family kinases.
|Butein, a specific protein tyrosine kinase inhibitor.
|RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells.
|Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
|Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral.
|beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
|The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.
|The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1.
|Differential actions of p60c-Src and Lck kinases on the Ras regulators p120-GAP and GDP/GTP exchange factor CDC25Mm.
|The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK.
|The DNA sequence and comparative analysis of human chromosome 20.
|Novel regulation and function of Src tyrosine kinase.
|Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1.
|Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.
|Regulation of cytochrome c oxidase activity by c-Src in osteoclasts.
|EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.
|Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions.
|Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.
|Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
|The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
|Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
|The C2 domain of PKCdelta is a phosphotyrosine binding domain.
|Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation.
|The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.
|Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.
|Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation.
|Patterns of somatic mutation in human cancer genomes.
|p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity.
|Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding.
|Phosphoproteome of resting human platelets.
|EGF mediates calcium-activated chloride channel activation in the human bronchial epithelial cell line 16HBE14o-: involvement of tyrosine kinase p60c-src.
|Regulation of estrogen rapid signaling through arginine methylation by PRMT1.
|Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
|New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
|Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.
|Large-scale proteomics analysis of the human kinome.
|The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling.
|The PDZ protein MPP2 interacts with c-Src in epithelial cells.
|Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
|Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.
|Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.
|The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
|Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.
|Heme controls the regulation of protein tyrosine kinases Jak2 and Src.
|The Cdc42-associated kinase ACK1 is not auto-inhibited but requires Src for activation.
|A direct interaction between the large GTPase dynamin-2 and FAK regulates focal adhesion dynamics in response to active Src.
|Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).
|PRR7 is a transmembrane adaptor protein expressed in activated T cells involved in regulation of T cell receptor signaling and apoptosis.
|Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.
|Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
|Toward a comprehensive characterization of a human cancer cell phosphoproteome.
|Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.
|An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
|A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.